HeartMate 2™

The HeartMate II™ LVAD is designed to provide short-term or long-term circulatory support for patients with advanced heart failure and is indicated in the United States for both target therapy and bridge to transplantation. Backed by over 10 years of data, the HeartMate II LVAD is the most widely used and most extensively studied LVAD in the world, implanted in more than 27,000 patients worldwide.

Description

Proven Results for Long-Term Support

The HeartMate II™ Left Ventricular Assist Device (LVAD) provides short- or long-term circulatory support for patients with moderate to severe heart failure. This small, quiet pump has a simple design – with only one moving part – and can deliver blood flow equivalent to that of a healthy heart.

UNIQUE REAL WORLD EXPERIENCE
More than 27,000 patients implanted with a HeartMate II LVAD

HeartMate II LVAD heart pump

THE MOST WIDELY USED AND EXTENSIVELY INVESTIGATED LVAD2

The HeartMate II LVAD is indicated in the United States for both target therapy and bridge transplantation. In addition, the HeartMate II LVAD is backed by over 10 years of clinical experience.

More than 27,000 heart failure patients have received the HeartMate II LVAD to date. Many have passed the 5 year milestone in therapy, and some are still in therapy more than 10 years later. These figures provide more than a decade of living evidence that the HeartMate II LVAD offers predictable surgical and clinical performance for better outcomes.

 

HEARTMATE II LVAD HAS MORE THAN 900 CLINICAL OR SCIENTIFIC PUBLICATIONS

Many patients have lived with the HeartMate II LVAD for more than 10 years
Proven Long-Term Patient Outcomes

Research has shown the HeartMate II LVAD:

Reverses and sustains reduction of heart failure symptoms8

Increases patients’ survival rates and quality of life compared with medical management alone9

  • reverses and sustainsreduction of heart failure symptoms
  • Improves patients’ survival rates and quality of life compared to medical treatment alone
TOP
Open chat